Non-Alcoholic Fatty Liver Disease Trial, Recruiting (NCT06619808)

Non-Alcoholic Fatty Liver Disease Trial, Recruiting NCT06619808 Sponsor: Jinling Hospital, China Condition: Non-Alcoholic Fatty Liver Disease

Printed from Voxsanity (voxsanity.com.au) — NCT06619808 — Data sourced from ClinicalTrials.gov. Verify directly with the trial site before attending. Not medical advice.

Back to Non Alcoholic Fatty Liver Disease

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

People who have been diagnosed with metabolic dysfunction-associated steatotic liver disease (a condition where fat builds up in the liver linked to metabolic health issues).

Who may not be able to join:

People who are not medically suitable for hyperbaric treatment (a therapy involving pressurised oxygen chambers) (confirm with trial site).
People who have received oxygen therapy within the past 6 months.
People with a history of certain liver conditions, including viral hepatitis, hemochromatosis, Wilson disease, autoimmune hepatitis, primary biliary cirrhosis, sclerosing cholangitis, biliary obstruction, or alpha-1 antitrypsin deficiency.
People who have serious organ problems or cancer.
People who have had a significant weight loss program or major surgery within the past 6 months.
People who are unable to give informed consent, or who are currently taking part in, or have taken part in, another clinical trial within the past 3 months.
People who are pregnant or breastfeeding.
People who have claustrophobia (fear of enclosed spaces) or who are unable to equalise ear pressure properly (confirm with trial site).

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.

Last synced 22 July 2026

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Miaofang Yang, MD, General Hospital of Eastern Theater Command, China

Phone: 800-555-5555

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Voxsanity

Clinical trials and treatments, explained plainly · voxsanity.com.au

Date:

To: My Doctor

Re: Clinical trial enquiry

I am writing to enquire about the following clinical trial which may be relevant to my care:

Trial: NCT06619808

Sponsor: Jinling Hospital, China

Phase: Not Applicable

Status: Recruiting

Condition: Non-Alcoholic Fatty Liver Disease

Trial contact: 800-555-5555

More information: https://clinicaltrials.gov/study/NCT06619808

Eligibility summary (AI generated)

Written by an AI model from the ClinicalTrials.gov eligibility criteria and checked on a sample basis. Please confirm against the original criteria.

Who might be able to join this trial:

People who have been diagnosed with metabolic dysfunction-associated steatotic liver disease (a condition where fat builds up in the liver linked to metabolic health issues).

Who may not be able to join:

People who are not medically suitable for hyperbaric treatment (a therapy involving pressurised oxygen chambers) (confirm with trial site).
People who have received oxygen therapy within the past 6 months.
People with a history of certain liver conditions, including viral hepatitis, hemochromatosis, Wilson disease, autoimmune hepatitis, primary biliary cirrhosis, sclerosing cholangitis, biliary obstruction, or alpha-1 antitrypsin deficiency.
People who have serious organ problems or cancer.
People who have had a significant weight loss program or major surgery within the past 6 months.
People who are unable to give informed consent, or who are currently taking part in, or have taken part in, another clinical trial within the past 3 months.
People who are pregnant or breastfeeding.
People who have claustrophobia (fear of enclosed spaces) or who are unable to equalise ear pressure properly (confirm with trial site).

Important: Always verify eligibility with the trial site directly before applying.

Access in Australia: A treatment being studied in a clinical trial is generally not yet listed on the PBS. Where a medicine is not approved or not available through a trial, the TGA Special Access Scheme may allow a doctor to access unapproved therapeutic goods for individual patients. See voxsanity.com.au/sas-navigator/ for a plain English explainer.

This information was sourced from ClinicalTrials.gov via Voxsanity (data last synced 22 July 2026). It is not medical advice. Please verify the trial's current status directly with the trial site before acting.

Trial details

Status

Recruiting

Phase

Not Applicable

Sponsor

Jinling Hospital, China

Registry

ClinicalTrials.gov

Start date

29 July 2024

Est. completion

1 August 2026

Where this trial is recruiting

🇨🇳 China

Primary endpoints

Change of liver stiffness; Change of liver fat content

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 22 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov